The novel 5‐HT1A receptor antagonist, SDZ 216–525, decreases 5‐HT release in rat hippocampus in vivo
Open Access
- 19 July 1993
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 109 (3) , 699-702
Abstract
Recent evidence suggests that the novel compound SDZ 216–525 is a selective and possibly silent 5‐HT1A receptor antagonist. Here we have examined the action of SDZ 216–525 on central 5‐HT1A autoreceptor function. The experiments involved measurement of drug effects on extracellular 5‐HT in the ventral hippocampus of the chloral hydrate anaesthetized rat by use of microdialysis. Acute injection of SDZ 216–525 (0.1, 0.3, 1.0 and 3 mg kg−1, s.c.) caused a dose‐related decrease in 5‐HT output with an estimated ED50 of at least 0.3 mg kg−1. This ED50 value is 20–30 times greater than ED50 values previously obtained for 8‐hydroxy‐2‐(di‐n‐propylamino) tetralin (8‐OH‐DPAT) and NAN‐190. In comparison, SDZ 216–525 is reported to have slightly higher affinity for the 5‐HT1A site than 8‐OH‐DPAT and NAN‐190. The inhibitory effect of SDZ 216–525 (1 mg kg−1, s.c.) on 5‐HT was blocked by the 5‐HT1/β‐adrenoceptor antagonist, (−)‐pindolol (8 mg kg−1, s.c.) but not by a combination of the β1 and β2‐selective adrenoceptor antagonists metoprolol and ICI 118,551 (4 mg kg−1, each). Although in several experimental models SDZ 216–525 has high affinity, selectivity and lacks intrinsic activity at the 5‐HT1A receptor, our experiments show that the drug decreases extracellular 5‐HT in ventral hippocampus of the chloral hydrate anaesthetized rat via a pindolol‐sensitive mechanism. We conclude that either SDZ 216–525 promotes (with low potency in vivo) 5‐HT1A receptor/G‐protein interactions, or that the 5‐HT1A autoreceptor is a 5‐HT1A receptor subtype different from the postsynaptic 5‐HT1A receptor.Keywords
This publication has 11 references indexed in Scilit:
- SDZ 216–525, a selective and potent 5-HT1A receptor antagonistEuropean Journal of Pharmacology: Molecular Pharmacology, 1993
- Pharmacological and Physicochemical Properties of Pre‐Versus Postsynaptic 5‐Hydroxytryptamine1A Receptor Binding Sites in the Rat Brain: A Quantitative Autoradiographic StudyJournal of Neurochemistry, 1992
- An intracellular study of the action of NAN-190 on neurons in the dorsal raphe nucleus of the ratBrain Research, 1992
- Agonist/antagonist interactions with cloned human 5-HT1A receptors: variations in intrinsic activity studied in transfected HeLa cellsNaunyn-Schmiedeberg's Archives of Pharmacology, 1992
- The putative 5-HT1A receptor antagonists NAN-190 and BMY 7378 are partial agonists in the rat dorsal raphe nucleus in vitroEuropean Journal of Pharmacology, 1992
- Effect of the putative 5-HT1A receptor antagonist NAN-190 on rat brain serotonergic transmissionEuropean Journal of Pharmacology, 1991
- Application of brain microdialysis to study the pharmacology of the 5-HT1A autoreceptorJournal of Neuroscience Methods, 1990
- Further investigation of the in vivo pharmacological properties of the putative 5-HT1A antagonist, BMY 7378European Journal of Pharmacology, 1990
- Mixed agonist/antagonist properties of NAN-190 at 5-HT1A Receptors: Behavioural and in vivo brain microdialysis studiesLife Sciences, 1990
- 5‐HT1 agonists reduce 5‐hydroxytryptamine release in rat hippocampus in vivo as determined by brain microdialysisBritish Journal of Pharmacology, 1989